Related Experiment Videos
Treatment in patients with glioblastoma multiforme and poor performance status: is it worthwhile?
F L Ampil1, A Nanda, B K Willis
1Department of Radiology, Louisiana State University Medical Center, Shreveport 71130, USA.
Radiation Medicine
|July 3, 1998
Abstract:
It has not been ascertained that treatment of glioblastoma multiforme of the brain (GMB) favorably alters the prognosis in patients with poor pretreatment performance status (PPS). We report on 52 patients with GMB and PPS. The mean survival of 43 treated persons was 19 +/- 12 months (95% confidence interval) and of nine untreated individuals, 2 +/- 1 months (p > 0.50); the corresponding survival rates at 1 year were 39 +/- 16% and 0% (p > 0.05) and at 2 years, 15 +/- 12% and 0% (p > 0.40). We recommend active treatment of patients with GMB even when they present with poor functional status.